Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
The 2019 Canadian Cardiovascular Congress The 2019 Canadian Cardiovascular Congress (CCC) is being held at the Palais des congrès de Montréal in Montréal, Québec from Thursday, October 24 to Sunday, October 27. […]
The Till & McCulloch Meetings are Canada's stem cell research conference. As the only conference of its kind in Canada, the Till & McCulloch Meetings provide an unparalleled opportunity for […]
Role of integrin alpha11beta1 in fibrotic disease The Gullberg laboratory has characterized the integrin α11β1, which is expressed on subsets of normal fibroblasts and on carcinoma-associated fibroblasts.
The Faculty of Dentistry at University of Toronto are hosting weekly research seminar series. The next seminar will be held on November 11, 12:30 - 1:30 pm at Faculty of […]
Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is a latent technology that could change biotech – and […]
The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. Medicine by Design, in partnership with […]
The Global Fibrosis Network will host a 1h-special seminar on November 21, 2019. Title: “Organs-on-Chips: A Platform for Drug Development and Disease Modeling” Speaker: Daniel Levner, Chief Technology Officer and […]
The fourth annual Medicine by Design Symposium will bring together principal investigators and trainees from across the University of Toronto and affiliated hospitals, along with members of its Scientific Advisory […]
Trainee Night: A Glimpse of Fibrosis Save the date December 5, 2019 4:00 – 6:00 PM TBEP Lounge, MaRS West Tower, 14th Floor The 3rd networking night of the Global […]
Please join us for an ECHO (Entrepreneurship for Cardiovascular Health Opportunities) seminar featuring Dr. Jennifer Moody (Chief Operating Officer, Morphocell Technologies) on Tuesday January 28, 2020 (11 am […]